Milbank advised Export Development Canada, while Davis Polk and Stikeman Elliott advised the underwriters. Export Development Canada announced the offering of $3.5 billion aggregate principal amount...
You must be a Standard 1 Year member to access this content.
Davis Polk and Homburger advised ADC Therapeutics, while Cooley and Lenz & Staehelin advised the underwriter. ADC Therapeutics SA announced a registered secondary offering of 12,000,000...
You must be a Standard 1 Year member to access this content.
Davis Polk and Hogan Lovells advised Precigen on the offering, and Goodwin Procter advised the underwriters involved. Precigen Inc. announced the SEC-registered offering of an aggregate of...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the joint book-running managers, while McCarthy Tétrault and Simpson Thacher advised Toronto-Dominion Bank on the offering. TD Bank announced an SEC-registered offering of $750 million aggregate...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini and Latham & Watkins advised Prometheus Biosciences on the deal, while Davis Polk & Wardwell advised the representatives of the several underwriters. Prometheus Biosciences,...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Immatics on the offering while Covington represented underwriters. Immatics N.V. executed its $110 million SEC-registered offering of ordinary shares. The ordinary shares are...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the placement agent, BofA Securities, Inc., in the offering. Solid Biosciences, Inc. executed its private placement of $75 million of common stock. The financing is...
You must be a Standard 1 Year member to access this content.
DLA Piper advised Medtronic Global Holdings, while Davis Polk advised the representatives of the several underwriters in the offering. Medtronic Global Holdings S.C.A. executed its offering of...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the underwriters in the offering. Export Development Canada issued the offering of $3.25 billion aggregate principal amount of 3.375% U.S. dollar bonds due 2025....
You must be a Standard 1 Year member to access this content.
Homburger and Davis Polk & Wardwell advised ADC Therapeutics on the deal. DC Therapeutics SA (NYSE:ADCT), a commercial-stage biotechnology company headquartered in Switzerland, announced that it...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Precigen on the deal. Precigen, Inc. executed the sale of its wholly-owned non-healthcare subsidiary, Trans Ova Genetics, L.C. (“Trans Ova”), an industry-leading animal...
You must be a Standard 1 Year member to access this content.
Paul, Weiss, Rifkind, Wharton & Garrison represented the Province of Saskatchewan, while Davis Polk & Wardwell advised the underwriters in the offering. McDougall Gauley, Stikeman Elliott...
You must be a Standard 1 Year member to access this content.
